+ A
A -
GENEVA: The World Health Organization announced on Wednesday that clinical trials of the drug hydroxychloroquine will resume as it searches for potential coronavirus treatments. More than 3,500 patients have been recruited across 35 countries to take part in the trials.
On May 25, the WHO announced it had temporarily suspended the trials to conduct a safety review, which has now concluded there is “no reason” to change the way the trials are conducted.
The UN health agency’s decision came after a study published in The Lancet medical journal suggesting the drug could increase the risk of death among COVID-19 patients. (AFP)
On May 25, the WHO announced it had temporarily suspended the trials to conduct a safety review, which has now concluded there is “no reason” to change the way the trials are conducted.
The UN health agency’s decision came after a study published in The Lancet medical journal suggesting the drug could increase the risk of death among COVID-19 patients. (AFP)
